Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Methanex
MEOH
$4.57B
| $15.6M | 0.02% |
274,926
-360,661
| -57% | -$20.3M |
|
952
SPDR Gold Trust
GLD
$155B
| $15.6M | 0.02% |
127,712
-50,958
| -29% | -$6.28M |
|
953
RTX Corp
RTX
$282B
| $15.6M | 0.02% |
192,045
-1,679,425
| -90% | -$128M |
|
|
TVTY
954
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $15.5M | 0.02% |
885,283
+17,627
| +2% | +$375K |
|
955
BioMarin Pharmaceuticals
BMRN
$12.6B
| $15.5M | 0.02% |
174,878
+68,586
| +65% | +$6.36M |
|
956
Consolidated Edison
ED
$39.8B
| $15.5M | 0.02% |
182,277
-960,035
| -84% | -$76.7M |
|
957
Ericsson
ERIC
$33.3B
| $15.4M | 0.02% |
1,682,321
-3,884,167
| -70% | -$35.1M |
|
958
LivePerson
LPSN
$33.2M
| $15.4M | 0.02% |
35,436
+839
| +2% | +$314K |
|
959
DXC Technology
DXC
$1.7B
| $15.4M | 0.02% |
239,229
-80,602
| -25% | -$5.15M |
|
960
Viasat
VSAT
$9.96B
| $15.3M | 0.02% |
197,687
-388,304
| -66% | -$27M |
|
961
FedEx
FDX
$79.1B
| $15.3M | 0.02% |
84,288
-252,794
| -75% | -$44.7M |
|
962
PUT
Bio-Rad Laboratories Class A
BIO
$10.2B
| $15.3M | 0.02% |
+50,000
| New | +$13.5M |
|
963
Emcor
EME
$33.7B
| $15.3M | 0.02% |
208,937
+985
| +0.5% | +$66.8K |
|
964
VanEck Junior Gold Miners ETF
GDXJ
$9.83B
| $15.2M | 0.02% |
480,513
+392,697
| +447% | +$12.5M |
|
|
ACHN
965
DELISTED
Achillion Pharmaceuticals
ACHN
| $15.2M | 0.02% |
5,144,173
+3,065,761
| +148% | +$7.53M |
|
966
Pampa Energía
PAM
$4.32B
| $15.2M | 0.02% |
552,261
+332,954
| +152% | +$11.2M |
|
|
GWPH
967
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $15.2M | 0.02% |
90,279
-70,779
| -44% | -$10.5M |
|
|
GSAH.U
968
DELISTED
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
| $15.2M | 0.02% |
1,450,000
| – | – |
|
969
Booking.com
BKNG
$160B
| $15.2M | 0.02% |
217,875
-3,388,200
| -94% | -$242M |
|
970
Vail Resorts
MTN
$5.35B
| $15.2M | 0.02% |
69,967
+39,998
| +133% | +$8.17M |
|
|
WW
971
DELISTED
WW International
WW
| $15.2M | 0.02% |
753,770
+353,925
| +89% | +$9.78M |
|
|
LSXMA
972
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $15.2M | 0.02% |
550,088
+2,432
| +0.4% | +$69.4K |
|
973
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$819B
| $15.1M | 0.02% |
53,500
-432,200
| -89% | -$117M |
|
|
LHCG
974
DELISTED
LHC Group LLC
LHCG
| $15.1M | 0.02% |
136,105
+132,016
| +3,229% | +$14.1M |
|
|
SEM
975
DELISTED
Select Medical
SEM
| $15.1M | 0.02% |
1,983,366
+545,051
| +38% | +$4.38M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.